Biomea Fusion Inc has a consensus price target of $24.85 based on the ratings of 14 analysts. The high is $60 issued by Oppenheimer on May 30, 2024. The low is $5 issued by Barclays on June 7, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Citigroup, and HC Wainwright & Co. on June 25, 2024, June 7, 2024, and June 7, 2024, respectively. With an average price target of $25 between HC Wainwright & Co., Citigroup, and HC Wainwright & Co., there's an implied 396.03% upside for Biomea Fusion Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/25/2024 | Buy Now | 197.62% | HC Wainwright & Co. | Joseph Pantginis | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
06/11/2024 | Buy Now | — | Truist Securities | Robyn Karnauskas | — | Downgrade | Buy → Hold | Get Alert |
06/07/2024 | Buy Now | 792.86% | Citigroup | Yigal Nochomovitz | $90 → $45 | Maintains | Buy | Get Alert |
06/07/2024 | Buy Now | 197.62% | HC Wainwright & Co. | Joseph Pantginis | $50 → $15 | Maintains | Buy | Get Alert |
06/07/2024 | Buy Now | 98.41% | Piper Sandler | Joseph Catanzaro | $45 → $10 | Maintains | Overweight | Get Alert |
06/07/2024 | Buy Now | -0.79% | Barclays | Peter Lawson | $30 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
06/07/2024 | Buy Now | 316.67% | Scotiabank | George Farmer | $41 → $21 | Maintains | Sector Outperform | Get Alert |
05/30/2024 | Buy Now | 1090.48% | Oppenheimer | Hartaj Singh | $70 → $60 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
05/03/2024 | Buy Now | 197.62% | JP Morgan | Eric Joseph | — | Maintains | Neutral | Get Alert |
04/03/2024 | Buy Now | 1288.89% | Oppenheimer | Hartaj Singh | → $70 | Maintains | Outperform | Get Alert |
04/02/2024 | Buy Now | 177.78% | JP Morgan | Gavin Scott | $51 → $14 | Downgrade | Overweight → Neutral | Get Alert |
04/01/2024 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | — | Reiterates | Buy → Buy | Get Alert |
04/01/2024 | Buy Now | 991.27% | Truist Securities | Robyn Karnauskas | → $55 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
02/06/2024 | Buy Now | 991.27% | Truist Securities | Robyn Karnauskas | → $55 | Initiates | → Buy | Get Alert |
12/08/2023 | Buy Now | 1685.71% | Citigroup | Yigal Nochomovitz | → $90 | Reiterates | Buy → Buy | Get Alert |
08/01/2023 | Buy Now | 753.17% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
08/01/2023 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
07/27/2023 | Buy Now | 713.49% | Scotiabank | George Farmer | → $41 | Initiates | → Sector Outperform | Get Alert |
07/25/2023 | Buy Now | 753.17% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
07/24/2023 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
07/12/2023 | Buy Now | 753.17% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | Buy Now | 455.56% | Jefferies | Eun Yang | $36 → $28 | Downgrade | Buy → Hold | Get Alert |
06/26/2023 | Buy Now | 792.86% | Piper Sandler | Joseph Catanzaro | $40 → $45 | Maintains | Overweight | Get Alert |
06/26/2023 | Buy Now | 911.9% | JP Morgan | Gavin Scott | $38 → $51 | Maintains | Overweight | Get Alert |
06/26/2023 | Buy Now | 1685.71% | Citigroup | Yigal Nochomovitz | $53 → $90 | Maintains | Buy | Get Alert |
06/26/2023 | Buy Now | 534.92% | EF Hutton | Michael King | → $32 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | Buy Now | 892.06% | HC Wainwright & Co. | Joseph Pantginis | $37 → $50 | Maintains | Buy | Get Alert |
05/25/2023 | Buy Now | 534.92% | EF Hutton | Michael King | → $32 | Assumes | → Buy | Get Alert |
05/18/2023 | Buy Now | 951.59% | Citigroup | Yigal Nochomovitz | $55 → $53 | Maintains | Buy | Get Alert |
05/12/2023 | Buy Now | 892.06% | Barclays | Peter Lawson | → $50 | Initiates | → Overweight | Get Alert |
05/04/2023 | Buy Now | 534.92% | EF Hutton | Michael King | $33 → $32 | Reiterates | → Buy | Get Alert |
05/03/2023 | Buy Now | 634.13% | HC Wainwright & Co. | Joseph Pantginis | → $37 | Reiterates | → Buy | Get Alert |
04/19/2023 | Buy Now | 634.13% | HC Wainwright & Co. | Joseph Pantginis | $44 → $37 | Maintains | Buy | Get Alert |
04/11/2023 | Buy Now | 832.54% | Oppenheimer | Hartaj Singh | → $47 | Reiterates | → Outperform | Get Alert |
04/07/2023 | Buy Now | 991.27% | Citigroup | Yigal Nochomovitz | $60 → $55 | Maintains | Buy | Get Alert |
04/06/2023 | Buy Now | 554.76% | EF Hutton | Michael King | → $33 | Reiterates | → Buy | Get Alert |
03/29/2023 | Buy Now | 832.54% | Oppenheimer | Hartaj Singh | $25 → $47 | Maintains | Outperform | Get Alert |
03/29/2023 | Buy Now | 1090.48% | Citigroup | Yigal Nochomovitz | $20 → $60 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | 773.02% | HC Wainwright & Co. | Joseph Pantginis | → $44 | Reiterates | → Buy | Get Alert |
03/28/2023 | Buy Now | 773.02% | HC Wainwright & Co. | Joseph Pantginis | $37 → $44 | Reiterates | → Buy | Get Alert |
03/28/2023 | Buy Now | 554.76% | EF Hutton | Michael King | $22 → $33 | Maintains | Buy | Get Alert |
03/28/2023 | Buy Now | 693.65% | Piper Sandler | Joseph Catanzaro | $16 → $40 | Maintains | Overweight | Get Alert |
03/24/2023 | Buy Now | 336.51% | Keefe, Bruyette & Woods | Michael King | → $22 | Reiterates | → Buy | Get Alert |
03/22/2023 | Buy Now | 336.51% | EF Hutton | Michael King | → $22 | Reiterates | → Buy | Get Alert |
03/21/2023 | Buy Now | 336.51% | EF Hutton | Michael King | → $22 | Reiterates | → Buy | Get Alert |
02/24/2023 | Buy Now | 296.83% | Citigroup | Yigal Nochomovitz | → $20 | Initiates | → Buy | Get Alert |
01/13/2023 | Buy Now | 634.13% | HC Wainwright & Co. | Joseph Pantginis | → $37 | Reiterates | → Buy | Get Alert |
11/08/2022 | Buy Now | 336.51% | EF Hutton | Michael King | $27 → $22 | Maintains | Buy | Get Alert |
11/01/2022 | Buy Now | 435.71% | EF Hutton | Michael King | → $27 | Initiates | → Buy | Get Alert |
10/31/2022 | Buy Now | 634.13% | HC Wainwright & Co. | Joseph Pantginis | $16 → $37 | Maintains | Buy | Get Alert |
06/02/2022 | Buy Now | 217.46% | HC Wainwright & Co. | Joseph Pantginis | → $16 | Assumes | → Buy | Get Alert |
01/12/2022 | Buy Now | 157.94% | HC Wainwright & Co. | Michael King | → $13 | Initiates | → Buy | Get Alert |
12/17/2021 | Buy Now | 336.51% | Oppenheimer | Hartaj Singh | — | Initiates | → Outperform | Get Alert |
The latest price target for Biomea Fusion (NASDAQ:BMEA) was reported by HC Wainwright & Co. on June 25, 2024. The analyst firm set a price target for $15.00 expecting BMEA to rise to within 12 months (a possible 197.62% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for Biomea Fusion (NASDAQ:BMEA) was provided by HC Wainwright & Co., and Biomea Fusion reiterated their buy rating.
There is no last upgrade for Biomea Fusion
The last downgrade for Biomea Fusion Inc happened on June 11, 2024 when Truist Securities changed their price target from N/A to N/A for Biomea Fusion Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biomea Fusion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biomea Fusion was filed on June 25, 2024 so you should expect the next rating to be made available sometime around June 25, 2025.
While ratings are subjective and will change, the latest Biomea Fusion (BMEA) rating was a reiterated with a price target of $15.00 to $15.00. The current price Biomea Fusion (BMEA) is trading at is $5.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.